<?xml version="1.0" encoding="UTF-8"?>
<ref id="CIT0056">
 <label>56</label>
 <mixed-citation publication-type="web">
  <person-group person-group-type="author">
   <string-name>
    <surname>Chupp</surname>
    <given-names>G</given-names>
   </string-name>, 
   <string-name>
    <surname>Vinetz</surname>
    <given-names>J.</given-names>
   </string-name>
  </person-group> The effect of camostat mesylate on COVID-19 infection in ambulatory patients: an investigator-initiated randomized, placebo-controlled, phase IIa trial. Yale University, Connecticut, USA. 
  <year>2020</year>. Available from: 
  <ext-link ext-link-type="uri" xlink:href="https://clinicaltrials.gov/ct2/show/NCT04353284" xmlns:xlink="http://www.w3.org/1999/xlink">https://clinicaltrials.gov/ct2/show/NCT04353284</ext-link>.
 </mixed-citation>
</ref>
